// App-Quantinova.ai

: A living interactive systematic review and network meta-analysis evaluating systemic therapies in metastatic castration-sensitive prostate cancer (mCSPC).

Researchers

Presenter

  • Irbaz Bin Riaz

Principal Investigators

  • Syed Arsalan Ahmed Naqvi

  • Huan He

  • Rabbia Siddiqi

  • Noureen Asghar

  • Praful Ravi

  • Syed A. Hussain

  • Parminder Singh

  • Alan Haruo Bryce

Medical Centers

  • University of Sheffield, Sheffield, United Kingdom

  • Dow University of Health Sciences, Karachi, Pakistan,

  • Mayo Clinic, Phoenix, AZ

  • Mayo Clinic Department of Digital Health, Rochester, MN

  • Dana-Farber Cancer Institute, Boston, MA

Locations

  • Pakistan

  • United Kingdom

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

  • Urology

Disease

  • Prostate cancer

Biomarkers

  • N/A

Drug/Treatment

  • Docetaxel

  • Androgen Tear

Outcome

  • N/A

Study Design

  • Randomized

  • Controlled

Phase

  • III

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved